Trial intelligence / Profile preview

Asciminib in pediatric chronic myeloid leukemia

NL-OMON61137Phase 2Recruiting

Sponsor

Novartis

Start

Aug 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1